News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Noninvasive Vagus Nerve Stimulation for Migraine and Primary Headache Disorders: Efficacy, Cost, and Impact on Quality of Life

Review of Evidence on Noninvasive Vagus Nerve Stimulation for Treatment of Migraine: Efficacy, Safety, and Implications

ByMkaya Mwamburi, MD, PhD,Andrew T. Tenaglia, BA,Eric J. Leibler,Peter S. Staats, MD, MBA

December 12th 2018

Noninvasive Vagus Nerve Stimulation in a Primary Care Setting: Effects on Quality of Life and Utilization Measures in Multimorbidity Patients With or Without Primary Headache

ByIain Strickland, PhD, BSc,Mkaya Mwamburi, MD, PhD,Steven Davis BSc,James C.R. Ward, MBBS,Janet Day, MBChB,Andrew T. Tenaglia, BA,Eric J. Leibler,Peter S. Staats, MD, MBA

December 12th 2018

Participating Faculty

By

December 12th 2018

Cost-effectiveness of Noninvasive Vagus Nerve Stimulation for Acute Treatment of Episodic Migraine and Role in Treatment Sequence Strategies

ByMkaya Mwamburi, MD, PhD,Andrew T. Tenaglia, BA,Eric J. Leibler,Peter S. Staats, MD, MBA

December 12th 2018

Trending on AJMC

FDA Approves Novel Iberdomide Regimen in RRMM

IL-17 Signaling Bridges Psoriasis and Cardiometabolic Risk, Review Finds

Employers With Claims Data Access Take More Cost Action, Survey Finds

CMS Final Rule Ends Federal Medicaid, CHIP Funding for Youth Gender-Affirming Care

Iberdomide Approval Elevates MRD’s Role in Myeloma: Prerna Mewawalla, MD